GNS Healthcare and Swedish Cancer Institute Launch Machine Learning Collaboration to Strengthen Delivery of Precision Medicine in Breast Cancer Care

Causal Computer Models to Accelerate Work of Swedish Cancer Institute’s Molecular Tumor Board CAMBRIDGE, Mass. and SEATTLE, Sept. 13, 2017 /PRNewswire/ — Leading precision medicine company GNS Healthcare (GNS) and the Swedish Cancer Institute (SCI) today announced a machine learning collaboration to strengthen, accelerate, and potentially expand the delivery of precision medicine in breast cancer care. GNS will employ its breakthrough causal machine learning and simulation […]